litlas
Log inCreate account

Robert A. Rissman

Active 1999–2025

155
Papers
18,241
Citations
71
h-index
140
i10-index

Citations

Citations per year for Robert A. Rissman1994: 1 citations1996: 1 citations2000: 4 citations2001: 9 citations2002: 13 citations2003: 12 citations2004: 21 citations2005: 18 citations2006: 35 citations2007: 18 citations2008: 50 citations2009: 37 citations2010: 62 citations2011: 60 citations2012: 75 citations2013: 61 citations2014: 76 citations2015: 79 citations2016: 90 citations2017: 141 citations2018: 212 citations2019: 615 citations2020: 920 citations2021: 1,159 citations2022: 1,129 citations2023: 999 citations2024: 1,454 citations2025: 941 citations2026: 34 citations1995: no citations, so this year is not shown1997–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,511 citing papers, 27.8% of this breakdownChina: 1,064 citing papers, 8.4% of this breakdownUnited Kingdom: 909 citing papers, 7.2% of this breakdownGermany: 592 citing papers, 4.7% of this breakdownSweden: 481 citing papers, 3.8% of this breakdownSpain: 479 citing papers, 3.8% of this breakdownItaly: 463 citing papers, 3.7% of this breakdownCanada: 414 citing papers, 3.3% of this breakdownFrance: 348 citing papers, 2.8% of this breakdownAustralia: 337 citing papers, 2.7% of this breakdownNetherlands: 322 citing papers, 2.5% of this breakdownIndia: 316 citing papers, 2.5% of this breakdown
0%27.8%Other 26.8%

Institutions

Fields

  • Medicine56.9%
  • Biochemistry, Genetics and Molecular Biology21.4%
  • Neuroscience13.9%
  • Immunology and Microbiology1.3%
  • Materials Science1%
  • Computer Science0.8%
  • Other4.7%

Topics

  • Alzheimer's disease research and treatments14.6%
  • Dementia and Cognitive Impairment Research7.1%
  • Neuroinflammation and Neurodegeneration Mechanisms4.7%
  • Parkinson's Disease Mechanisms and Treatments3%
  • Cholinesterase and Neurodegenerative Diseases2.1%
  • Extracellular vesicles in disease1.9%
  • Other66.6%

Coauthors

All papers

Open in search
  1. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report

    Authors: Peter T. Nelson, Dennis W. Dickson, John Q. Trojanowski, Clifford R. Jack, Patricia A. Boyle, Konstantinos Arfanakis, Rosa Rademakers, Irina Alafuzoff, Johannes Attems, Carol Brayne, Ian Coyle‐Gilchrist, Helena C. Chui, David W. Fardo, Margaret E. Flanagan, Glenda M. Halliday, Suvi R. K. Hokkanen, Sally Hunter, Gregory A. Jicha, Yuriko Katsumata, Claudia H. Kawas, C. Dirk Keene, Gábor G. Kovács, Walter A. Kukull, Allan I. Levey, Nazanin Makkinejad, Thomas J. Montine, Shigeo Murayama, Melissa E. Murray, Sukriti Nag, Robert A. Rissman, William W. Seeley, Reisa A. Sperling, Charles L. White, Lei Yu, Julie A. Schneider - Brain 2019 cited by 1,546

  2. Brain cell type–specific enhancer–promoter interactome maps and disease - risk association

    Authors: Alexi Nott, Inge R. Holtman, Nicole G. Coufal, Johannes C. M. Schlachetzki, Miao Yu, Rong Hu, Claudia Z. Han, Monique Pena, Jiayang Xiao, Yin Wu, Zahara Keulen, Martina P. Pasillas, Carolyn O’Connor, Christian K. Nickl, Simon T. Schafer, Zeyang Shen, Robert A. Rissman, James B. Brewer, David Gosselin, David Gonda, Michael L. Levy, Michael G. Rosenfeld, Graham McVicker, Fred H. Gage, Bing Ren, Christopher K. Glass - Science 2019 cited by 810

  3. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease

    Authors: Charbel Moussa, Michaeline Hebron, Xu Huang, Jaeil Ahn, Robert A. Rissman, Paul Aisen, Raymond Scott Turner - Journal of Neuroinflammation 2017 cited by 691

  4. The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease

    Authors: Michael S. Rafii, Reisa A. Sperling, Michael Donohue, Jin Zhou, Claire Roberts, Michael C. Irizarry, Shobha Dhadda, Gopalan Sethuraman, Lynn D. Kramer, Chad J. Swanson, David Li, Stephen Krause, Robert A. Rissman, Sarah Walter, Rema Raman, Keith A. Johnson, Paul Aisen - Alzheimer s & Dementia 2022 cited by 264

  5. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

    Authors: Raymond Scott Turner, Ronald G. Thomas, Suzanne Craft, Christopher H. van Dyck, Jacobo Mintzer, Brigid Reynolds, James B. Brewer, Robert A. Rissman, Rema Raman, Paul Aisen, For the Alzheimer's Disease Cooperative Study, Alzheimer's Disease Cooperative Study, Jacobo Mintzer, Brent A. Reynolds, Jason Karlawish, Douglas Galasko, Judith L. Heidebrink, Neel Aggarwal, Neill R. Graff‐Radford, Mary Sano, Ronald C. Petersen, Katheryn A. Bell, Rachelle S. Doody, Alisha J Smith, Charles Bernick, A. Porteinsson, Pierre N. Tariot, Ruth A. Mulnard, A. Lerner, Luisa‐Sophie Schneider, Jane C. Burns, Murray A. Raskind, Steven H. Ferris, Gregory A. Jicha, M. Quiceno, Thomas O. Obisesan, Paul B. Rosenberg, Daniel Weintraub, Karl Kieburtz, Bruce L. Miller, Richard J. Kryscio, G. Alexopoulis - Neurology 2015 cited by 699

  6. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

    Authors: Ganesh M. Babulal, Yakeel T. Quiroz, Benedict C. Albensi, Eider M. Arenaza‐Urquijo, Arlene Astell, Claudio Babiloni, Alex Bahar‐Fuchs, J. Simon Bell, Gene L. Bowman, Adam M. Brickman, Gaël Chételat, Carrie Ciro, Ann D. Cohen, Peggye Dilworth‐Anderson, Hiroko H. Dodge, Simone Dreux, Steven D. Edland, Anna J. Esbensen, Lisbeth Evered, Michael Ewers, Keith N. Fargo, Juan Fortea, Hector M. González, Deborah Gustafson, Elizabeth Head, James A. Hendrix, Scott M. Hofer, Leigh Johnson, Roos J. Jutten, Kerry Kilborn, Krista L. Lanctôt, Jennifer J. Manly, Ralph N. Martins, Michelle M. Mielke, Martha Clare Morris, Melissa E. Murray, Esther S. Oh, Mario A. Parra, Robert A. Rissman, Catherine M. Roe, Octavio A. Santos, Nikolaos Scarmeas, Lon S. Schneider, Nicole Schupf, Sietske A.M. Sikkes, Heather M. Snyder, Hamid R. Sohrabi, Yaakov Stern, André Strydom, Yi Tang, Graciela Muñiz‐Terrera, Charlotte E. Teunissen, Debora Melo van Lent, Michael Weinborn, Linda M.P. Wesselman, Donna M. Wilcock, Henrik Zetterberg, Sid E. O’Bryant - Alzheimer s & Dementia 2018 cited by 539

  7. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia

    Authors: Suzanne Craft, Rema Raman, Tiffany W. Chow, Michael S. Rafii, Chung‐Kai Sun, Robert A. Rissman, Michael Donohue, James B. Brewer, Cecily Jenkins, Kelly Harless, Devon Gessert, Paul Aisen - JAMA Neurology 2020 cited by 368

  8. Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease

    Authors: Robert A. Rissman, Oliver Langford, Rema Raman, Michael Donohue, Sara Abdel‐Latif, Matthew R. Meyer, Traci L. Wente‐Roth, Kristopher M. Kirmess, Jennifer Ngolab, Charisse N. Winston, Gustavo Jimenez‐Maggiora, Michael S. Rafii, Pallavi Sachdev, Tim West, Kevin E. Yarasheski, Joel B. Braunstein, Michael C. Irizarry, Keith A. Johnson, Paul Aisen, Reisa A. Sperling, for the AHEAD 3‐45 Study team - Alzheimer s & Dementia 2023 cited by 145

  9. Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change

    Authors: Denis S. Smirnov, Nicholas J. Ashton, Kaj Blennow, Henrik Zetterberg, Joel Simrén, Juan Lantero‐Rodriguez, Thomas K. Karikari, Annie Hiniker, Robert A. Rissman, David P. Salmon, Douglas Galasko - Acta Neuropathologica 2022 cited by 227

  10. The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease

    Authors: Ji‐Yeun Hur, Georgia Frost, Xianzhong Wu, Christina J. Crump, Si Pan, Eitan Wong, Marilia Barros, Thomas Li, Pengju Nie, Yujia Zhai, Jen Chyong Wang, Julia TCW, Lei Guo, Andrew McKenzie, Ming Chen, Xianxiao Zhou, Minghui Wang, Yotam Sagi, Alan E. Renton, Bianca Esposito, Yong Kim, Katherine R. Sadleir, Ivy Trinh, Robert A. Rissman, Robert Vassar, Bin Zhang, Douglas S. Johnson, Eliezer Masliah, Paul Greengard, Alison Goate, Yue‐Ming Li - Nature 2020 cited by 394

  11. LATE-NC staging in routine neuropathologic diagnosis: an update

    Authors: Peter T. Nelson, Edward B. Lee, Matthew D. Cykowski, Irina Alafuzoff, Konstantinos Arfanakis, Johannes Attems, Carol Brayne, María M. Corrada, Brittany N. Dugger, Margaret E. Flanagan, Bernardino Ghetti, Lea T. Grinberg, Murray Grossman, Michel J. Grothe, Glenda M. Halliday, Masato Hasegawa, Suvi R. K. Hokkanen, Sally Hunter, K. A. Jellinger, Claudia H. Kawas, C. Dirk Keene, Naomi Kouri, Gábor G. Kovács, James B. Leverenz, Caitlin S. Latimer, Ian R. Mackenzie, Qinwen Mao, Kirsty E. McAleese, Richard L. Merrick, Thomas J. Montine, Melissa E. Murray, Liisa Myllykangas, Sukriti Nag, Janna H. Neltner, Kathy L. Newell, Robert A. Rissman, Yuko Saito, S. Ahmad Sajjadi, Katherine E. Schwetye, Andrew F. Teich, Dietmar Rudolf Thal, Sandra O. Tomé, Juan C. Troncoso, Shih‐Hsiu J. Wang, Charles L. White, Thomas Wısnıewskı, Hyun‐Sik Yang, Julie A. Schneider, Dennis W. Dickson, Manuela Neumann - Acta Neuropathologica 2022 cited by 176

  12. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile

    Authors: Charisse N. Winston, Edward J. Goetzl, Johnny Akers, Bob S. Carter, Edward Rockenstein, Douglas Galasko, Eliezer Masliah, Robert A. Rissman - Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2016 cited by 386

  13. Functional Amyloids As Natural Storage of Peptide Hormones in Pituitary Secretory Granules

    Authors: Samir K. Maji, Marilyn H. Perrin, M.R. Sawaya, Sebastian Jessberger, Krishna C. Vadodaria, Robert A. Rissman, Praful S. Singru, K. Peter R. Nilsson, Rozalyn Simon, David Schubert, David Eisenberg, Jean Rivier, Paul E. Sawchenko, Wylie Vale, Roland Riek - Science 2009 cited by 1,063

  14. miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer’s Patients

    Authors: Diana J. Cha, David Mengel, Maja Mustapić, Wen Liu, Dennis J. Selkoe, Dimitrios Kapogiannis, Douglas Galasko, Robert A. Rissman, David A. Bennett, Dominic M. Walsh - Frontiers in Neuroscience 2019 cited by 207

  15. Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer Disease

    Authors: Michael S. Rafii, Mark H. Tuszynski, Ronald G. Thomas, David Barba, James B. Brewer, Robert A. Rissman, João Siffert, Paul Aisen, for the AAV2-NGF Study Team - JAMA Neurology 2018 cited by 209

  16. Early neuronal accumulation of DNA double strand breaks in Alzheimer’s disease

    Authors: Niraj M. Shanbhag, Mark D. Evans, Wenjie Mao, Alissa L. Nana, William W. Seeley, Anthony Adame, Robert A. Rissman, Eliezer Masliah, Lennart Mucke - Acta Neuropathologica Communications 2019 cited by 219

  17. The Health & Aging Brain among Latino Elders (HABLE) study methods and participant characteristics

    Authors: Sid E. O’Bryant, Leigh Johnson, Robert C. Barber, Meredith N. Braskie, Bradley T. Christian, James Hall, Nalini Hazra, Kevin S. King, Deydeep Kothapalli, Stephanie Large, David Mason, Elizabeth Matsiyevskiy, Roderick McColl, Rajesh Nandy, Raymond F. Palmer, Melissa Petersen, Nicole Philips, Robert A. Rissman, Yonggang Shi, Arthur W. Toga, Raul Vintimilla, Rocky Vig, Fan Zhang, Kristine Yaffe, for the HABLE Study Team - Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2021 cited by 119

  18. Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders

    Authors: Vivian Hook, Michael C. Yoon, Charles Mosier, Gen Ito, Sonia Podvin, Brian P. Head, Robert A. Rissman, Anthony J. O’Donoghue, Gregory Hook - Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2020 cited by 168

  19. Guidelines for the standardization of preanalytic variables for blood‐based biomarker studies in Alzheimer's disease research

    Authors: Sid E. O’Bryant, Veer Bala Gupta, Kim Henriksen, Melissa Edwards, Andreas Jeromin, Simone Lista, Chantal Bazenet, Holly Soares, Simon Lovestone, Harald Hampel, Thomas J. Montine, Kaj Blennow, Tatiana Foroud, María C. Carrillo, Neill R. Graff‐Radford, Christoph Laske, Monique M.B. Breteler, Leslie M. Shaw, John Q. Trojanowski, Nicole Schupf, Robert A. Rissman, Anne M. Fagan, Pankaj Oberoi, Robert M. Umek, Michael W. Weiner, Paula Grammas, Holly Posner, Ralph N. Martins, STAR-B and BBBIG working groups - Alzheimer s & Dementia 2014 cited by 288

  20. Pathogenesis of Alzheimer's disease: Involvement of the choroid plexus

    Authors: Mária Čarná, Isaac G. Onyango, Stanislav Katina, Dušan Holub, Jan Novotný, Markéta Nezvedová, Durga Jha, Zuzana Nedelská, Valentina Lacovich, Thijs Vande Vyvere, Ruben Houbrechts, Krystine Garcia‐Mansfield, Ritin Sharma, Victoria David‐Dirgo, Martin Vyhnálek, Kateřina Texlova, Hernán Chaves, Nadine Bakkar, Lucía Pertierra, Mojmír Vinkler, Hana Marková, Jan Laczó, Kateřina Sheardová, Marcela Hortová Kohoutková, Jan Frič, Giancarlo Forte, Petr Kaňovský, Silvie Bělašková, Jiřı́ Damborský, Jakub Hort, Nicholas T. Seyfried, Robert Bowser, Gustavo Sevlever, Robert A. Rissman, Richard Smith, Marián Hajdúch, Patrick Pirrotte, Zdeněk Spáčil, Eric B. Dammer, Clara Limbäck‐Stokin, Gorazd B. Stokin - Alzheimer s & Dementia 2023 cited by 90

  21. Association of Neighborhood-Level Disadvantage With Alzheimer Disease Neuropathology

    Authors: W. Ryan Powell, William R. Buckingham, Jamie L. Larson, Leigha Vilen, Menggang Yu, M. Shahriar Salamat, Barbara B. Bendlin, Robert A. Rissman, Amy Kind - JAMA Network Open 2020 cited by 188

  22. Blood‐based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic

    Authors: Sid E. O’Bryant, Michelle M. Mielke, Robert A. Rissman, Simone Lista, Hugo Vanderstichele, Henrik Zetterberg, Piotr Lewczuk, Holly Posner, James Hall, Leigh Johnson, Y L Fong, Johan Luthman, Andreas Jeromin, Richard Batrla‐Utermann, Alcibiades E. Villarreal, Gabrielle B. Britton, Peter J. Snyder, Kim Henriksen, Paula Grammas, Veer Bala Gupta, Ralph N. Martins, Harald Hampel, Biofluid Based Biomarker Professional Interest Area - Alzheimer s & Dementia 2016 cited by 311

  23. Association of Neighborhood-Level Disadvantage With Cerebral and Hippocampal Volume

    Authors: Jack F.V. Hunt, William Buckingham, Alice J. Kim, Jennifer M. Oh, N. Vogt, Erin M. Jonaitis, Tenah K.A. Hunt, Megan Zuelsdorff, W. Ryan Powell, Derek Norton, Robert A. Rissman, Sanjay Asthana, Ozioma C. Okonkwo, Sterling C. Johnson, Amy Kind, Barbara B. Bendlin - JAMA Neurology 2020 cited by 157

  24. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models

    Authors: Michiyo Iba, Changyoun Kim, Michelle A. Sallin, Somin Kwon, Anjali Verma, Cassia Overk, Robert A. Rissman, Ranjan Sen, Jyoti Misra Sen, Eliezer Masliah - Journal of Neuroinflammation 2020 cited by 132